Journal of General Internal Medicine

, Volume 32, Issue 7, pp 767–774

Public Awareness of and Contact With Physicians Who Receive Industry Payments: A National Survey

  • Genevieve Pham-Kanter
  • Michelle M. Mello
  • Lisa Soleymani Lehmann
  • Eric G. Campbell
  • Daniel Carpenter
Original Research

Abstract

Background

The Physician Payments Sunshine Act, part of the Affordable Care Act, requires pharmaceutical and medical device firms to report payments they make to physicians and, through its Open Payments program, makes this information publicly available.

Objective

To establish estimates of the exposure of the American patient population to physicians who accept industry payments, to compare these population-based estimates to physician-based estimates of industry contact, and to investigate Americans’ awareness of industry payments.

Design

Cross-sectional survey conducted in late September and early October 2014, with data linkage of respondents’ physicians to Open Payments data.

Participants

A total of 3542 adults drawn from a large, nationally representative household panel.

Main Measures

Respondents’ contact with physicians reported in Open Payments to have received industry payments; respondents’ awareness that physicians receive payments from industry and that payment information is publicly available; respondents’ knowledge of whether their own physician received industry payments.

Key Results

Among the 1987 respondents who could be matched to a specific physician, 65% saw a physician who had received an industry payment during the previous 12 months. This population-based estimate of exposure to industry contact is much higher than physician-based estimates from the same period, which indicate that 41% of physicians received an industry payment. Across the six most frequently visited specialties, patient contact with physicians who had received an industry payment ranged from 60 to 85%; the percentage of physicians with industry contact in these specialties was much lower (35–56%). Only 12% of survey respondents knew that payment information was publicly available, and only 5% knew whether their own doctor had received payments.

Conclusions

Patients’ contact with physicians who receive industry payments is more prevalent than physician-based measures of industry contact would suggest. Very few Americans know whether their own doctor has received industry payments or are aware that payment information is publicly available.

KEY WORDS

financial conflicts of interest physician-industry relationships industry payments physician payments sunshine act open payments 

Supplementary material

11606_2017_4012_MOESM1_ESM.pdf (132 kb)
ESM 1(PDF 132 kb)

References

  1. 1.
    Section 6002 of the Patient Protection and Affordable Care Act. Public Law 111–148. http://www.gpo.gov/fdsys/pkg/PLAW-111publ148/pdf/PLAW-111publ148.pdf. Accessed 26 Jan 2017.
  2. 2.
    Centers for Medicare and Medicaid Services. 42 CFR Parts 402 and 403. Medicare, Medicaid, Children’s Health Insurance Programs; transparency reports and reporting of physician ownership or investment interests. Federal Register 78. 2013. https://www.cms.gov/OpenPayments/Downloads/Affordable-Care-Act-Section-6002-Final-Rule.pdf. Accessed 26 Jan 2017.
  3. 3.
    Official website for Open Payments. https://www.cms.gov/OpenPayments/index.html. Accessed 26 Jan 2017.
  4. 4.
    US Senate Special Committee on Aging. Grassley, Kohl say public should know when pharmaceutical makers give money to doctors. Press release. September 7, 2007. http://www.aging.senate.gov/press-releases/grassley-kohl-say-public-should-know-when-pharmaceutical-makers-give-money-to-doctors. Accessed 26 Jan 2017.
  5. 5.
    Chimonas S, Rozario NM, Rothman DJ. Show us the money: lessons in transparency from state pharmaceutical marketing disclosure laws. Health Serv Res. 2010;45:98–114.CrossRefPubMedPubMedCentralGoogle Scholar
  6. 6.
    Hampson LA, Agrawal M, Joffe S, Gross CP, Verter J, Emanuel EJ. Patients’ views on financial conflicts of interest in cancer research trials. N Engl J Med. 2006;355:2330–2337.CrossRefPubMedGoogle Scholar
  7. 7.
    Hwong AR, Qaragholi N, Carpenter D, Joffe S, Campbell EG, Lehmann LS. A systematic review of state and manufacturer physician payment disclosure websites: implications for implementation of the Sunshine Act. J Law Med Ethics. 2014;42:208–219.CrossRefPubMedGoogle Scholar
  8. 8.
    Licurse A, Barber E, Joffe S, Gross C. The impact of disclosing financial ties in research and clinical care: a systematic review. Arch Intern Med. 2010;170:675–682.CrossRefPubMedGoogle Scholar
  9. 9.
    Lo B, Field MJ, eds. Conflict of interest in medical research, education, and practice. Washington, DC: National Academies Press; 2009.Google Scholar
  10. 10.
    Rosenbaum L. Understanding bias - the case for careful study. N Engl J Med. 2015;372:1959–1963.CrossRefPubMedGoogle Scholar
  11. 11.
    Rosenthal MB, Mello MM. Sunlight as disinfectant - new rules on disclosure of industry payments to physicians. N Engl J Med. 2013;368:2052–2054.CrossRefPubMedGoogle Scholar
  12. 12.
    Santhakumar S, Adashi EY. The Physician Payment Sunshine Act: testing the value of transparency. JAMA. 2015;313:23–24.CrossRefPubMedGoogle Scholar
  13. 13.
    Steinbrook R. Online disclosure of physician-industry relationships. N Engl J Med. 2009;360:325–327.CrossRefPubMedGoogle Scholar
  14. 14.
    Weinfurt KP, Friedman JY, Allbrook JS, Dinan MA, Hall MA, Sugarman J. Views of potential research participants on financial conflicts of interest. J Gen Intern Med. 2006;21:906–906.CrossRefGoogle Scholar
  15. 15.
    Pham-Kanter G. Act II of the Sunshine Act. PLoS Med. 2014; e1001754.Google Scholar
  16. 16.
    Campbell EC, Gruen RL, Moutford J, et al. A national survey of physician-Industry relationships. N Engl J Med. 2007;356:1742–50.CrossRefPubMedGoogle Scholar
  17. 17.
    Fleischman W, Ross JS, Melnick ER, Newman DH, Venkatesh AK. Financial ties between emergency physicians and industry: insights from Open Payments data. Ann Emerg Med. 2016;68:153–158.e4.CrossRefPubMedGoogle Scholar
  18. 18.
    Iyer S, Derman P, Sandhu HS. Orthopaedics and the Physician Payments Sunshine Act. J Bone Joint Surg Am. 2016;98, e18 (1–9).CrossRefPubMedGoogle Scholar
  19. 19.
    Kesselheim AS, Robertson CT, Siri K, Batra P, Franklin JM. Distributions of industry payments to Massachusetts physicians. N Engl J Med. 2013;368:2049–2052.CrossRefPubMedGoogle Scholar
  20. 20.
    Marshall DC, Jackson ME, Hattangadi-Gluth JA. Disclosure of industry payments to physicians: an epidemiologic analysis of early data from the Open Payments program. Mayo Clin Proc. 2016;91:84–96.CrossRefPubMedPubMedCentralGoogle Scholar
  21. 21.
    Parikh K, Fleischman W, Agrawal S. Industry relationships with pediatricians: findings from the Open Payments Sunshine Act. Pediatrics. 2016;137:320154440.CrossRefGoogle Scholar
  22. 22.
    Rathi VK, Samuel AM, Mehra S. Industry ties in otolaryngology: initial insights from the Physician Payment Sunshine Act. Otolaryngol Head Neck Surg. 2015;152:993–999.CrossRefPubMedGoogle Scholar
  23. 23.
    Pew Research Center. Assessing the representativeness of public opinion surveys. 2012. http://www.people-press.org/2012/5/15/assessing-the-representativeness-of-public-opinion-surveys. Accessed 26 Jan 2017.
  24. 24.
    Manfreda KL, Bosnjak M, Berzelak J, Haas I, Vehovar V. Web surveys versus other survey modes: a meta-analysis comparing response rates. Int J Mark Res. 2008;50:79–104.Google Scholar
  25. 25.
    National Research Council. Nonresponse in social science surveys: a research agenda. Tourangeau R, Plewes TJ, eds. Panel on a research agenda for the future of social science data collection, Committee on National Statistics, Division of Behavioral and Social Sciences and Education, National Research Council. Washington, DC: National Academies Press; 2013.Google Scholar
  26. 26.
    Sismondo S. Key opinion leaders and the corruption of medical knowledge: what the Sunshine Act will and won’t cast light on. J Law Med Ethics. 2013;41(3):635–43.CrossRefPubMedGoogle Scholar
  27. 27.
    Schneider EC, Epstein AM. Use of public performance reports: a survey of patients undergoing cardiac surgery. JAMA. 1998;279(20):1638–1642.CrossRefPubMedGoogle Scholar
  28. 28.
    Hannan EL, Sarrazin MS, Doran DR, Rosenthal GE. Provider profiling and quality improvement efforts in coronary artery bypass graft surgery: the effect on short-term mortality among Medicare beneficiaries. Med Care. 2003;41(10):1164–1172.CrossRefPubMedGoogle Scholar

Copyright information

© Society of General Internal Medicine 2017

Authors and Affiliations

  • Genevieve Pham-Kanter
    • 1
  • Michelle M. Mello
    • 2
  • Lisa Soleymani Lehmann
    • 3
    • 4
  • Eric G. Campbell
    • 5
  • Daniel Carpenter
    • 6
  1. 1.Department of Health Management and Policy, Drexel University Dornsife School of Public Health, and Leonard Davis Institute of Health Economics, University of PennsylvaniaPhiladelphiaUSA
  2. 2.Stanford Law School, and Department of Health Research and Policy, Stanford University School of MedicineStanfordUSA
  3. 3.Department of Medicine and Center for Bioethics, Harvard Medical School, and Department of Health Policy and ManagementHarvard T. H. Chan School of Public HealthBostonUSA
  4. 4.National Center for Ethics in Health CareVeterans Health AdministrationWashingtonUSA
  5. 5.Mongan Institute for Health Policy, Massachusetts General Hospital, and Harvard Medical SchoolBostonUSA
  6. 6.Department of Government and Radcliffe Institute for Advanced StudyHarvard UniversityCambridgeUSA

Personalised recommendations